EPCAM and cancer: Finally, we validated the potential of ITGAV to identify hybrid/plastic cancer cells by analyzing the expression of ITGAV and EpCAM in epithelial, mixed, and mesenchymal mouse cSCCs through standard clinical methods such as IF (Fig. 2E).